Origin: Derived from thiamine
Also Known As: S-benzoylthiamine O-monophosphate
Overview: Benfotiamine is a synthetic S-acyl derivative of thiamine first developed and invented in Japan in 1961. It is marketed as a dietary supplement in the US and in China and as a pharmaceutical drug in Ukraine, Russia, India, Korea, and Japan.
It is typically markets asn aon over-the-counter drug for diabetic neuropathy. Studies have shown that taking benfotiamine increases blood levels of vitamin B1 five times more than an equal dose of thiamine supplements.
- Improving complications from diabetes
- Improving mental function
- Protecting liver from damage
- Reducing the harmful effects of smoking
- Protecting the kidneys during dialysis
- Improving symptoms of Alzheimer’s disease
- Reducing Advanced glycation end-products (AGEs)
- Inhibiting the growth of leukemic tumors
- Improving post heart attack recovery rate
- Reducing inflammation
Common Dosage: According to clinical trials, the most effective dosage of benfotiamine is 300 mg to 600 mg divided into two doses per day.